-
1.
公开(公告)号:US20110184017A1
公开(公告)日:2011-07-28
申请号:US13055031
申请日:2009-07-24
IPC分类号: A61K31/4725 , A61P27/02 , A61P27/06 , B65D85/00 , B65B3/04
CPC分类号: A61K31/4725 , A61K9/0048 , A61K9/08
摘要: An aqueous solution composition containing (S)-1-(4-chloro-5-isoquinolinesulfonyl)-3-aminopyrrolidine or (S)-1-(4-chloro-5-isoquinolinesulfonyl)-3-(methylamino)pyrrolidine as an active ingredient, and not containing citric acid or a salt thereof, which has high stability so as to be storable at room temperature.
摘要翻译: 含有(S)-1-(4-氯-5-异喹啉磺酰基)-3-氨基吡咯烷或(S)-1-(4-氯-5-异喹啉磺酰基)-3-(甲基氨基)吡咯烷作为活性的水溶液组合物 成分,不含柠檬酸或其盐,其稳定性高,可在室温下保存。
-
公开(公告)号:US20090156823A1
公开(公告)日:2009-06-18
申请号:US12216257
申请日:2008-07-01
IPC分类号: C07D217/22
CPC分类号: C07D401/12
摘要: (S)-1-(4-Chloro-5-isoquinolinesulfonyl)-3-(methylamino)pyrrolidine monohydrochloride and a crystal thereof, and a crystal of the aforementioned monohydrochloride having a major peak or peaks at one or more positions selected from the group consisting of positions where 2θs are about 13.9°, 21.5°, 21.7°, 22.4°, 22.8°, 24.5° and 35.0° in a powder X-ray diffraction spectrum, which have excellent properties as active ingredient of a medicament for prophylactic and/or therapeutic treatment of glaucoma and the like.
摘要翻译: (S)-1-(4-氯-5-异喹啉磺酰基)-3-(甲基氨基)吡咯烷一盐酸盐及其结晶,以及上述一盐酸盐的结晶,在一个或多个位置上具有主峰或峰 包括在粉末X射线衍射光谱中2θ为13.9°,21.5°,21.7°,22.4°,22.8°,24.5°和35.0°的位置,其作为用于预防和/ 或治疗青光眼等。
-
公开(公告)号:US08232292B2
公开(公告)日:2012-07-31
申请号:US12216257
申请日:2008-07-01
IPC分类号: A61K31/47 , C07D401/02
CPC分类号: C07D401/12
摘要: (S)-1-(4-Chloro-5-isoquinolinesulfonyl)-3-(methylamino)pyrrolidine monohydrochloride and a crystal thereof, and a crystal of the aforementioned monohydrochloride having a major peak or peaks at one or more positions selected from the group consisting of positions where 2θs are about 13.9°, 21.5°, 21.7°, 22.4°, 22.8°, 24.5° and 35.0° in a powder X-ray diffraction spectrum, which have excellent properties as active ingredient of a medicament for prophylactic and/or therapeutic treatment of glaucoma and the like.
摘要翻译: (S)-1-(4-氯-5-异喹啉磺酰基)-3-(甲基氨基)吡咯烷一盐酸盐及其结晶,以及上述一盐酸盐的结晶,在一个或多个位置上具有主峰或峰 由粉末X射线衍射光谱中的2和等级为13.9°,21.5°,21.7°,22.4°,22.8°,24.5°和35.0°的位置组成,其作为预防药物的活性成分具有优异的性质 和/或治疗性青光眼等。
-
-